Raising Capital & Forming Strategic Partnerships with Industry in the Medical Device Universe – Hosted by JLabs

As 2020 came to a close, investors focused on later-stage clinical and commercialized opportunities which led to a decline of the total number of medical device Series A deals across all indications.

Although the number of Series A deals was down, investment dollars were higher for Cardiovascular and Neurology indications, suggesting there may be a late-stage investor appetite in specific disease states.

Data from Q1 2021 suggests a promising upward trend in Series A deals, significantly ahead of 2019 and 2020 pace. However, concerns remain for the plight of ‘early-stage’ med device companies in capital raise mode.

What can early-stage medical device companies make of this information as they set out for strategic partnerships? This interactive discussion will highlight best practices for Med Device ventures on how to raise a Seed & Series A round.

Specifically, the discussion will focus on:

• Med Device Investor appetite for ‘early-stage’ companies

• VC and Corporate Partnership Term Sheet Negotiations for early-stage Ventures

• Major inflection points (milestones) to garner VC or Industry interests in an early-stage company

• Alternative sources of funding